BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/24/2025 3:48:38 AM | Browse: 127 | Download: 476
 |
Received |
|
2025-05-19 03:54 |
|
Peer-Review Started |
|
2025-05-19 03:54 |
|
First Decision by Editorial Office Director |
|
2025-06-05 08:26 |
|
Return for Revision |
|
2025-06-05 08:26 |
|
Revised |
|
2025-06-17 12:05 |
|
Publication Fee Transferred |
|
2025-06-18 07:20 |
|
Second Decision by Editor |
|
2025-08-22 02:31 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-08-29 10:11 |
|
Articles in Press |
|
2025-08-29 10:11 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-09-06 15:06 |
|
Publish the Manuscript Online |
|
2025-09-24 03:48 |
| ISSN |
1948-0210 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, Research & Experimental |
| Manuscript Type |
Basic Study |
| Article Title |
Exploring the critical therapeutic window: Dose-frequency optimization of human umbilical cord mesenchymal stem cells for preclinical asthma treatment
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Qiong-Hua Chen, Jing-Yang Zheng, Yu-Qin Zhu, Jun-Yao Zhang, Chun-Yan Lin, Xue-E Zhuang, Jing Cheng and Xiao-Yi Huang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Joint Innovation Project Funds of Huaqiao University |
2022YX001 |
|
| Corresponding Author |
Qiong-Hua Chen, Deputy Director, /, The Graduate School of Fujian Medical University, No. 1 Xuefu North Road, Shangjie Town, Minhou County, Fuzhou 350122, Fujian Province, China. cqionghua283@163.com |
| Key Words |
Asthma; Human umbilical cord mesenchymal stem cells; Mouse; Dose; Frequency |
| Core Tip |
This study reports, human umbilical cord blood-derived mesenchymal stem cell (HUC-MSC) therapy shows potential for treating asthma with high purity. HUC-MSC has been demonstrated to modulate airway remodeling, enhance lung function, and inhibit the inflammatory response in acute ovalbumin-induced asthma model. This study provides appropriate reference dosages to explore the possible intervention of HUC-MSC further. A single dosage of 2 × 105 cells is optimal, while double treatments with 2 × 105 cells may be optimal in reducing airway obstruction, but not for modulating airway inflammation. |
| Publish Date |
2025-09-24 03:48 |
| Citation |
Chen QH, Zheng JY, Zhu YQ, Zhang JY, Lin CY, Zhuang XE, Cheng J, Huang XY. Exploring the critical therapeutic window: Dose-frequency optimization of human umbilical cord mesenchymal stem cells for preclinical asthma treatment. World J Stem Cells 2025; 17(9): 109715 |
| URL |
https://www.wjgnet.com/1948-0210/full/v17/i9/109715.htm |
| DOI |
https://dx.doi.org/10.4252/wjsc.v17.i9.109715 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
